Latest blood cancer News | Page 3

Blood stem cell research that could change medicine of future
Emotional connection to Legacy Week
COVID vaccines and antiviral medications: update for immunocompromised children and adults with cancer
Covid oral treatments
Acquisition of TeneoTwo for its clinical-stage T-cell engager completed
Breakthrough in precision medicine for treatment of acute myeloid leukaemia
Authorisation request for proposed settlement between pharmaceutical companies withdrawn
City of Canada Bay awards over $180,000 to community groups
Expanded Eligibility Criteria for Covid Oral Antiviral Treatments
Mum, I’ve got this. You don’t need to worry
New research identifies more effective weapon against blood cancers
AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening haematological cancer pipeline
McGowan Government’s Innovation Seed Fund awards $8 million across 17 health and medical innovation initiatives
New PBS listings from 1 July 2022
Goldilocks treatment window could lead to cancer therapy without harmful side-effects
$270 million to accelerate med tech innovation
Australians call for equitable access to new era in fighting cancer
AstraZeneca demonstrates pipeline and portfolio strength across malignant and rare haematological diseases
Immune therapy targets cells that cause leukemia relapse
Blood Cancer – Professor Miles Prince – World Blood Cancer Day
Study reveals potential therapies for aggressive lymphoma
Taking on blood cancer – actively
Major discovery provides new hope for blood cancer patients
Bridgestone Maintains Most Trusted Tyre Brand status across Australia and New Zealand
Race receives human ethics approval for new trial
Novel acute myeloid leukemia subtypes identified
John Dick and Zulfiqar Bhutta win Canada Gairdner Awards
Blood cancer research supported with $5m grant
Blood cancer research supported with $5m award
ACCC not satisfied of claimed benefits from proposed settlement between pharmaceutical companies
AstraZeneca’s antibody combination, Evusheld▼ authorised for use
Programming Immune System to Supercharge Cancer Cell Therapies
Ludwig Stanford study solves long-sought protein structure, shows how mutation drives blood cancers
Researchers uncover genetic ‘bridge’ to leukemia progression
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
Rare cancer treatment approved by Pharmaceutical Benefits Scheme
Arovella Therapeutics closes over-subscribed share purchase plan
Australians With One Of Most Agressive Forms Of Blood Cancer Have New PBS Listed Treatment Option
Lymphoma cell metabolism may provide new cancer target
Cancer-causing ‘junk’ under microscope
Beagle’s sudden blindness reveals stage 5 lymphoma
2022 Fellowships to support improved health outcomes for cancer patients
Highly Cited Researchers 16 November
AstraZeneca advances ambition to redefine care for blood cancer at ASH 2021
$2m NHMRC success for Centenary Institute researchers
2021 Research Excellence Awards celebrate three of WA’s brightest researchers
Study offers hope for deadly side effect of bone marrow transplants
New and amended PBS listings to help thousands of Australians